On Friday, Gain Therapeutics Inc (NASDAQ: GANX) opened higher 10.00% from the last session, before settling in for the closing price of $3.5. Price fluctuations for GANX have ranged from $1.41 to $3.65 over the past 52 weeks.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -37.02%. Company’s average yearly earnings per share was noted 27.65% at the time writing. With a float of $37.06 million, this company’s outstanding shares have now reached $38.46 million.
Gain Therapeutics Inc (GANX) Insider Activity
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Gain Therapeutics Inc is 3.64%, while institutional ownership is 11.29%.
Gain Therapeutics Inc (GANX) Earnings and Forecasts
If we go through the results of last quarter, which was made public on 12/31/2024, the company posted -0.08 earnings per share (EPS) for the quarter, besting the agreed prediction (set at -0.19) by 0.11. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.16 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 27.65% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 2.30% during the next five years compared to -37.02% drop over the previous five years of trading.
Gain Therapeutics Inc (NASDAQ: GANX) Trading Performance Indicators
Check out the current performance indicators for Gain Therapeutics Inc (GANX). In the past quarter, the stock posted a quick ratio of 2.52.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.64, a number that is poised to hit -0.14 in the next quarter and is forecasted to reach -0.71 in one year’s time.
Technical Analysis of Gain Therapeutics Inc (GANX)
Compared to the last year’s volume of 0.48 million, its volume of 1.24 million showed improvement in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 81.54%.
During the past 100 days, Gain Therapeutics Inc’s (GANX) raw stochastic average was set at 94.94%, which indicates a significant increase from 90.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.33 in the past 14 days, which was higher than the 0.19 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $2.33, while its 200-day Moving Average is $1.95. Nevertheless, the first resistance level for the watch stands at $4.06 in the near term. At $4.28, the stock is likely to face the second major resistance level. The third major resistance level sits at $4.57. If the price goes on to break the first support level at $3.55, it is likely to go to the next support level at $3.26. Should the price break the second support level, the third support level stands at $3.04.
Gain Therapeutics Inc (NASDAQ: GANX) Key Stats
There are currently 38,462K shares outstanding in the company with a market cap of 148.08 million. Presently, the company’s annual sales total 0 K according to its annual income of -20,410 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -5,280 K.
